Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19

Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb(®) adsorption device are applied in the treatment of severe COVID‐19. The CytoSorb(®) adsorber consists of porous polymer beads that adsorb a broad range of molecules, including cytokines but also several therapeutic drugs....

Descripción completa

Detalles Bibliográficos
Autores principales: Biever, Paul, Staudacher, Dawid L., Sommer, Michaela J., Triebel, Hannah, Neukamm, Merja A., Bode, Christoph, Supady, Alexander, Lother, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953359/
https://www.ncbi.nlm.nih.gov/pubmed/33710753
http://dx.doi.org/10.1002/prp2.743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953359/
https://www.ncbi.nlm.nih.gov/pubmed/33710753
http://dx.doi.org/10.1002/prp2.743

Ejemplares similares